Literature DB >> 19800613

Peripheral exudative hemorrhagic chorioretinopathy: a clinical, angiographic, and histologic study.

Irmela Mantel1, Sylvie Uffer, Leonidas Zografos.   

Abstract

PURPOSE: To describe the clinical and angiographic characteristics of peripheral exudative hemorrhagic chorioretinopathy, an uncommon chorioretinal mass lesion, important for its differential diagnosis to choroidal melanoma, but only rarely described in the literature.
DESIGN: Retrospective, institutional chart review.
METHODS: Institutional chart review of 45 patients (56 eyes) diagnosed with peripheral exudative hemorrhagic chorioretinopathy to describe the clinical findings and those obtained by fluorescein angiography (FA) and indocyanine green angiography (ICGA), in addition to a review of the histologic findings of an enucleated eye.
RESULTS: Peripheral exudative hemorrhagic chorioretinopathy typically was characterized by increased age of the patient (mean, 77 years; range, 60 to 91 years), female preponderance (69%), frequent pigment epithelium detachment, temporal equatorial location, and a highly hemorrhagic and exudative presentation, sometimes extending to the macula. Bilateral involvement (24%) was associated with multiples lesions in the same eye (P < .001) and with nasal extension (P < .001). A neovascular origin was suspected on FA, but was more evident on ICGA. Histologic examination of the enucleated eye did not reveal a neovascular network.
CONCLUSIONS: Peripheral exudative hemorrhagic chorioretinopathy is a characteristic peripheral degenerative disorder, frequently with benign outcome, although it can be vision threatening because of hemorrhage or exudation. Clinical features are helpful for its diagnosis. FA and ICGA contribute valuable evidence to the hypothesis of a neovascular origin, but further histologic studies are needed to prove this hypothesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19800613     DOI: 10.1016/j.ajo.2009.06.032

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  17 in total

1.  Prevalence of peripheral abnormalities on ultra-widefield greenlight (532 nm) autofluorescence imaging at a tertiary care center.

Authors:  Florian M Heussen; Colin S Tan; SriniVas R Sadda
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-21       Impact factor: 4.799

2.  Intravitreal bevacizumab injection for peripheral exudative hemorrhagic chorioretinopathy.

Authors:  María Socorro Alforja; Noelia Sabater; Joan Giralt; Alfredo Adán; Laura Pelegrín; Ricardo Casaroli-Marano
Journal:  Jpn J Ophthalmol       Date:  2011-06-02       Impact factor: 2.447

3.  [Unclear uveal tumor with bleeding].

Authors:  R Angermann; G Haas; M Hofer; M Stattin; N E Bechrakis; C Zehetner
Journal:  Ophthalmologe       Date:  2018-12       Impact factor: 1.059

4.  Anti-VEGF therapy in symptomatic peripheral exudative hemorrhagic chorioretinopathy (PEHCR) involving the macula.

Authors:  Ira Seibel; Annette Hager; Tobias Duncker; Aline I Riechardt; Daniela Nürnberg; Julian P Klein; Matus Rehak; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-07-07       Impact factor: 3.117

5.  Progressive Massive Choroidal Neovascularization, an Aggressive Phenotype: Case Report.

Authors:  Renata García-Franco; Marlon García-Roa; Roberto Cárdenas-Almagro; Diego Valera-Cornejo; Sergio E Hernández-Da Mota
Journal:  Case Rep Ophthalmol       Date:  2022-06-28

6.  Evanescent vaso-occlusive choroidal pseudo-tumor with acute painful onset: a presumed vortex vein occlusion.

Authors:  Irmela Mantel; Ann Schalenbourg; Leonidas Zografos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-12-21       Impact factor: 3.117

7.  Management of peripheral polypoidal choroidal vasculopathy with intravitreal bevacizumab and indocyanine green angiography-guided laser photocoagulation.

Authors:  Pukhraj Rishi; Atheeswar Das; Pallavi Sarate; Ekta Rishi
Journal:  Indian J Ophthalmol       Date:  2012 Jan-Feb       Impact factor: 1.848

8.  Surgical Management of Hemorrhagic Retinal Detachment Secondary to Peripheral Exudative Hemorrhagic Chorioretinopathy.

Authors:  Valmore A Semidey; Abdulaziz A Al Taisan; Patrik Schatz; Ibrahim Taskintuna; Marco Mura
Journal:  Middle East Afr J Ophthalmol       Date:  2021-04-30

9.  Effects of nanoencapsulation and PEGylation on biodistribution of indocyanine green in healthy mice: quantitative fluorescence imaging and analysis of organs.

Authors:  Baharak Bahmani; Christian Y Lytle; Ameae M Walker; Sharad Gupta; Valentine I Vullev; Bahman Anvari
Journal:  Int J Nanomedicine       Date:  2013-04-22

10.  Treatment of peripheral exudative hemorrhagic chorioretinopathy by intravitreal injections of ranibizumab.

Authors:  Kei Takayama; Tosio Enoki; Teruo Kojima; Sho Ishikawa; Masaru Takeuchi
Journal:  Clin Ophthalmol       Date:  2012-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.